Work is in progress in several laboratories to isolate small molecules that inhibit the IKKs, and whose activities in some tumours lead to constitutive NF-κB activation and in others, such as breast cancer, where IKKα plays an important role in proliferation. This evidence concerns the gene NFKB1 and breast carcinoma.